Objective:
To provide clinical recommendations for optometric care regarding the ocular risks associated with GLP-1 receptor agonists.
Key Findings:
- GLP-1s are linked with worsening diabetic retinopathy (DR).
- GLP-1s are associated with nonarteritic anterior ischemic optic neuropathy (NAION).
- Recent findings suggest a link between GLP-1s and neovascular age-related macular degeneration.
Interpretation:
The report emphasizes the need for optometrists to be aware of the ocular risks when managing patients on GLP-1 receptor agonists.
Limitations:
- The report is limited to the context of optometric care and may not cover all aspects of GLP-1s' systemic effects.
Conclusion:
Optometrists should integrate the findings from the report into their practice to better manage patients using GLP-1 receptor agonists.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.